Skip navigation

Chemical Organometallic Compounds

1–50 of 6,048 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Phenobarbital [Phenobarbital results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene 1: Rattus norvegicus Liver | Microsomes   1
2. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Iron | Phenobarbital [[Phenobarbital results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene] which results in increased abundance of Iron 1: Rattus norvegicus Liver | Microsomes   1
3. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process NADP [NADP results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene 1: Rattus norvegicus Liver | Microsomes   1
4. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Iron | NADP [[NADP results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene] which results in increased abundance of Iron 1: Rattus norvegicus Liver | Microsomes   1
5. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Oxygen [Oxygen results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene 1: Rattus norvegicus Liver | Microsomes   1
6. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Iron | Oxygen [[Oxygen results in increased exogenous drug catabolic process] which results in increased degradation of 3,5,5-trimethylhexanoylferrocene] which results in increased abundance of Iron 1: Rattus norvegicus Liver | Microsomes   1
7. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Carbon Monoxide [Carbon Monoxide results in decreased exogenous drug catabolic process] which results in decreased degradation of 3,5,5-trimethylhexanoylferrocene 1: Rattus norvegicus Liver | Microsomes   1
8. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Carbon Monoxide | Iron [[Carbon Monoxide results in decreased exogenous drug catabolic process] which results in decreased degradation of 3,5,5-trimethylhexanoylferrocene] which results in decreased abundance of Iron 1: Rattus norvegicus Liver | Microsomes   1
9. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Piperonyl Butoxide [Piperonyl Butoxide results in decreased exogenous drug catabolic process] which results in decreased degradation of 3,5,5-trimethylhexanoylferrocene 1: Rattus norvegicus Liver | Microsomes   1
10. 3,5,5-trimethylhexanoylferrocene exogenous drug catabolic process Iron | Piperonyl Butoxide [[Piperonyl Butoxide results in decreased exogenous drug catabolic process] which results in decreased degradation of 3,5,5-trimethylhexanoylferrocene] which results in decreased abundance of Iron 1: Rattus norvegicus Liver | Microsomes   1
11. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
12. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
13. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebellum | Cytoplasm   1
14. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity 1: Rattus norvegicus Cerebellum | Mitochondria   1
15. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
16. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
17. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
18. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
19. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Cytoplasm   1
20. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Cytoplasm   1
21. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity phosphocreatine catabolic process [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Mitochondria   1
22. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process 1: Rattus norvegicus Cerebellum | Mitochondria   1
23. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
24. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
25. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebellum | Cytoplasm   1
26. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione Glutathione inhibits the reaction [3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] 1: Rattus norvegicus Cerebellum | Mitochondria   1
27. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
28. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity | Glutathione Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Cytoplasm   1
29. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
30. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity | Glutathione Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebral Cortex | Mitochondria   1
31. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Cytoplasm   1
32. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity | Glutathione Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Cytoplasm   1
33. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one creatine kinase activity Glutathione | phosphocreatine catabolic process Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Mitochondria   1
34. 3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one phosphocreatine catabolic process creatine kinase activity | Glutathione Glutathione inhibits the reaction [[3-butyl-1-phenyl-2-(phenyltelluro)oct-2-en-1-one results in decreased creatine kinase activity] which results in decreased phosphocreatine catabolic process] 1: Rattus norvegicus Cerebellum | Mitochondria   1
35. 4-hydroxymercuribenzoate cellular hypotonic response 4-hydroxymercuribenzoate results in decreased cellular hypotonic response 1: Homo sapiens Granulosa Cells | Cells, Cultured   1
36. 4-hydroxymercuribenzoate cellular hypotonic response positive regulation of cell volume [4-hydroxymercuribenzoate results in decreased cellular hypotonic response] which results in decreased positive regulation of cell volume 1: Homo sapiens Granulosa Cells | Cells, Cultured   1
37. 4-hydroxymercuribenzoate positive regulation of cell volume cellular hypotonic response [4-hydroxymercuribenzoate results in decreased cellular hypotonic response] which results in decreased positive regulation of cell volume 1: Homo sapiens Granulosa Cells | Cells, Cultured   1
38. aluminum maltolate cell death aluminum maltolate results in increased cell death 1: Rattus norvegicus PC12 Cells   1
39. aluminum maltolate cell death Buthionine Sulfoximine [aluminum maltolate co-treated with Buthionine Sulfoximine] results in increased cell death 1: Rattus norvegicus PC12 Cells   1
40. aluminum maltolate cell death Acetylcysteine Acetylcysteine inhibits the reaction [aluminum maltolate results in increased cell death] 1: Rattus norvegicus PC12 Cells   1
41. aluminum maltolate cell proliferation aluminum maltolate results in decreased cell proliferation 1: Homo sapiens Neurons | Cell Line, Tumor
6 genes: AKT1 | BAX | BCL2 | BCL2L1 | GDNF | TP53
1
42. aluminum maltolate reactive oxygen species metabolic process aluminum maltolate results in increased reactive oxygen species metabolic process 1: Homo sapiens Neurons | Cell Line, Tumor 1 gene: BCL2 1
43. aluminum maltolate cell proliferation quinoline-val-asp(OMe)-CH2-OPH quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [aluminum maltolate results in decreased cell proliferation] 1: Homo sapiens Neurons | Cell Line, Tumor
6 genes: AKT1 | BAX | BCL2 | BCL2L1 | GDNF | TP53
1
44. aluminum maltolate apoptotic process aluminum maltolate results in increased apoptotic process 1: Homo sapiens Neurons | Cell Line, Tumor
16 genes: AKT1 | APP | BAX | BCL2 | BCL2L1 | BECN1 | CASP12 | CASP3 | CASP9 | CYCS | DDIT3 | MAPK1 | MAPK3 | TNF | TP53 | TRP53
1
45. aluminum maltolate apoptotic process quinoline-val-asp(OMe)-CH2-OPH quinoline-val-asp(OMe)-CH2-OPH inhibits the reaction [aluminum maltolate results in increased apoptotic process] 1: Homo sapiens Neurons | Cell Line, Tumor
16 genes: AKT1 | APP | BAX | BCL2 | BCL2L1 | BECN1 | CASP12 | CASP3 | CASP9 | CYCS | DDIT3 | MAPK1 | MAPK3 | TNF | TP53 | TRP53
1
46. AMD 6221 regulation of blood pressure Phenylephrine AMD 6221 affects the reaction [Phenylephrine results in increased regulation of blood pressure] 1: Canis lupus familiaris Blood Vessels   1
47. ammonium ferric sulfate apoptotic process ammonium ferric sulfate results in decreased apoptotic process 1: Homo sapiens Mammary Glands, Human | Cell Line, Tumor
2 genes: HMOX1 | TF
1
48. ammonium ferric sulfate porphyrin-containing compound biosynthetic process Glutethimide ammonium ferric sulfate promotes the reaction [Glutethimide results in increased porphyrin-containing compound biosynthetic process] 1: Gallus gallus Hepatocytes | Cells, Cultured   1
49. ammonium ferric sulfate porphyrin-containing compound biosynthetic process Glutethimide | Uroporphyrins ammonium ferric sulfate promotes the reaction [[Glutethimide results in increased porphyrin-containing compound biosynthetic process] which results in increased abundance of Uroporphyrins] 1: Gallus gallus Hepatocytes | Cells, Cultured   1
50. ammonium ferrous sulfate lipid oxidation Edetic Acid | Enzymes and Coenzymes | Flavin Mononucleotide | NADP | Sodium Chloride [Flavin Mononucleotide co-treated with Sodium Chloride co-treated with Edetic Acid co-treated with ammonium ferrous sulfate co-treated with NADP metabolite co-treated with Enzymes and Coenzymes] results in increased lipid oxidation 1: Rattus norvegicus     1
1–50 of 6,048 results.